← Eichor
Study identifier: NCT06447168 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment

Condition: Primary Biliary Cholangitis  ·  Sponsor: Ipsen

PhaseN/A
Planned participants424
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

This study will collect information from participants with Primary Biliary Cholangitis (PBC) as they use the drug elafibranor in real world setting. PBC is a progressive rare liver disease in which tubes in the liver called bile ducts are damaged. The liver damage in PBC may lead to scarring (cirrhosis). PBC may also be associated with multiple symptoms including pruritus (itching) and fatigue. Many patients with PBC may require liver transplant or may die if the disease progresses and a liver transplant is not done. In this study the main aim is to observe the effectiveness, safety and tolerability of elafibranor in participants with PBC who are receiving treatment in real world setting. The total study duration for each participants will be 60 months (approximately 5 years).

This description comes directly from the study's public registry record.

Talk to the study team

Ipsen Clinical Study Enquiries  ·  See e mail  ·  clinical.trials@ipsen.com

Always discuss trial participation with your own doctor first.

Locations (68)

Southern California Research CenterCoronado, California, United StatesRecruiting
Cedars-Sinai Medical CenterLos Angeles, California, United StatesNot Yet Recruiting
University of California Davis Medical CenterSacramento, California, United StatesRecruiting
South Denver Gastroenterology,P.C.Englewood, Colorado, United StatesRecruiting
Yale University School of MedicineNew Haven, Connecticut, United StatesRecruiting
Schiff Center for Liver Diseases - University of MiamiMiami, Florida, United StatesRecruiting
Beth Israel Deaconess Medical Center, Liver Research CenterBoston, Massachusetts, United StatesRecruiting
Virtua Center for Liver Disease - Cherry HillCherry Hill, New Jersey, United StatesRecruiting
Northwell Health Inc, Center for Liver Disease and TransplantationManhasset, New York, United StatesRecruiting
UNC Hospitals, The University of North Carolina at Chapel HillChapel Hill, North Carolina, United StatesRecruiting
Cleveland Clinic FoundationCleveland, Ohio, United StatesRecruiting
Medical University of South Carolina (MUSC)Charleston, South Carolina, United StatesRecruiting

+ 56 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06447168